Susanna Naggie, MD

Publications

Collins, LF, Chan, A, Zheng, J, Chow, S-C, Wilder, JM, Muir, AJ, and Naggie, S. "Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection." Open forum infectious diseases 5, no. 1 (January 2018): ofx264-.

PMID
29308413
Full Text

Morgan, JR, Kim, AY, Naggie, S, and Linas, BP. "The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets." Open forum infectious diseases 5, no. 1 (January 2018): ofx267-.

PMID
29354660
Full Text

Lok, AS, Chung, RT, Vargas, HE, Kim, AY, Naggie, S, and Powderly, WG. "Benefits of direct-acting antivirals for Hepatitis C." Annals of Internal Medicine 167, no. 11 (December 5, 2017): 812-813.

Full Text

Powderly, WG, Naggie, S, Kim, AY, Vargas, HE, Chung, RT, and Lok, AS. "IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C." CLINICAL INFECTIOUS DISEASES 65, no. 11 (December 1, 2017): 1773-1775.

Full Text

Lok, AS, Chung, RT, Vargas, HE, Kim, AY, Naggie, S, and Powderly, WG. "Benefits of Direct-Acting Antivirals for Hepatitis C." Annals of Internal Medicine 167, no. 11 (December 2017): 812-813.

PMID
29049502
Full Text

Zuckerman, A, Chastain, CA, and Naggie, S. "Retreatment Options Following HCV Direct Acting Antiviral Failure." Current treatment options in infectious diseases 9, no. 4 (December 2017): 389-402.

PMID
29242710
Full Text

Powderly, WG, Naggie, S, Kim, AY, Vargas, HE, Chung, RT, and Lok, AS. "IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 65, no. 11 (November 2017): 1773-1775.

PMID
29020156
Full Text

Lok, AS, Chung, RT, Vargas, HE, Kim, AY, Naggie, S, and Powderly, WG. "Comments on cochrane review on direct-acting antivirals for hepatitis C." Hepatology (Baltimore, Md.) 66, no. 4 (October 2017): 1016-1019.

PMID
28714142
Full Text

Naggie, S, Fierer, DS, Hughes, M, Kim, AY, Luetkemeyer, A, Vu, V, Roa, J, Brainard, DM, McHutchison, JG, Peters, MG, Kiser, JJ, Marks, KM, and Chung, RT. "100% SVR with 8 weeks of ledipasvir/sofosbuvir in HIV-infected Men with Acute HCV Infection: Results from the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute HCV in HIV-1 Infected Individuals)." October 2017.

Scholars@Duke

Wyles, D, Bräu, N, Kottilil, S, Daar, ES, Ruane, P, Workowski, K, Luetkemeyer, A, Adeyemi, O, Kim, AY, Doehle, B, Huang, KC, Mogalian, E, Osinusi, A, McNally, J, Brainard, DM, McHutchison, JG, Naggie, S, Sulkowski, M, and ASTRAL-5 Investigators, . "Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 65, no. 1 (July 2017): 6-12.

PMID
28369210
Full Text

Pages